Dr. Chirantan Bose
MBBS, MD, MBA, MS Molecular Oncology,
Head, Department of Molecular and Precision
Oncology
MOC (Mumbai Oncocare Centre) Cancer Care and
Research
Dr. Chirantan Bose is one of the few experts of Molecular Oncology in India who brings the unique combination of skills in Applied Molecular Oncology, translations into management of advanced cancer patients, pivoting high-impact research, and leadership in precision medicine. With two decades of experience in advanced cancer management, he heads the Department of Molecular and Precision Oncology at India’s leading Medical Oncology hospital network, MOC in Mumbai. Here, he bridges the gap between cancer genomics and the practice of precision medicine, wherein treatment protocols for advanced and complex cancers are personalized, so as to attain best outcomes.
Education and Professional Journey
He received his medical training from Gandhi Medical
College Bhopal, Karolinska Institute Sweden, the University of Pittsburgh
Medical Centre (UPMC), USA, the University of South Wales UK, and the Centre of
BioSciences Spain. Additionally, he has received management training at
IIT-Bombay and Washington University Business School USA. He has played pivotal
roles with prestigious cancer care institutions and oncology research groups
across Asia, USA, Canada, Australia, Africa, and the GCC. His extensive experience
includes a broad spectrum of clinical-commercial leadership roles, establishing
large-scale, state-of-the-art precision oncology and cancer care services.
Expertise and Specialization in Cancer Care
Dr. Chirantan Bose highlights that cancer incidence is
rising worldwide, with India anticipating one of the steepest increases in the
next decade. He believes that cancer care can no longer follow the dictum of
“One size fits all.” Dr Bose said “Personalized treatment options, encompassing
a wide range of chemotherapeutic agents, should be customized to each patient
to ensure the best outcomes and avoid the adverse effects of ineffective drugs.”
In his extensive clinical studies, personalized treatment
regimens have shown extremely favorable outcomes, exemplifying that
personalized medicine is essential. Dr Chirantan Bose collaborates with medical
oncologists to design comprehensive treatment plans based on molecular and
cellular events from cancer patients, aiming to enhance survival outcomes even
in the most advanced and complex cancers.
He also emphasizes the importance of cancer screening and early diagnosis. Dr Bose has been instrumental in developing cutting-edge liquid biopsy and blood-based assays for cancer screening, early detection, and non-invasive monitoring of cancer patients. These advanced tools, including AI-based predictive tools, help in managing the ever growing menace of cancer better.
Achievements and Awards
Among the few trained and practicing molecular oncologists
in the country, Dr Chirantan Bose has also received a Gold Medal from
IIT-Bombay for standing first in the MBA program provided jointly by IIT-Bombay
and Washington University. Despite his numerous accolades, he considers his
connection with the medical fraternity and patients his greatest asset.
Dr. Chirantan Bose has received several prestigious awards,
including "The Most Eminent Doctor in Oncology" from MT Healthcare in
January 2024 and the "Molecular Pathologist of the Year" award from
Voice of Healthcare in February 2024. Dr Bose alongwith the team of experts at
MOC provide tele-consultation and second opinion services to cancer patients
across over 15 countries. He has established molecular tumor boards, enabling
patients worldwide to access expert opinions from India and cost-effective
treatment and diagnostic services. These initiatives aim to reduce the cost of
advanced cancer care and make India an attractive destination for cancer
treatment for overseas patients.
He was instrumental in launching India's first blood-based cancer screening test (Liquid Biopsy), capable of screening for 70 different cancers with a simple blood test, significantly reducing treatment costs and other issues associated with advanced-stage cancer diagnosis. Dr Chirantan Bose has authored over 20 eminent publications in the past two years and has developed educational resources for patients and oncologists.
Research Contributions
Dr. Chirantan Bose is developing an AI-based
decision-making tool to enhance the management of advanced and complex cancers
and also to enable oncologists all over the world to assess patients more
objectively & forecast personalized cancer outcomes. This AI-based smart
tool will also help patients connect with Precision Oncology services remotely.
Currently, Dr Chirantan is actively engaged in publishing and presenting real-world Indian data on the impact of Molecular Oncology in enhancing cancer patient survival. This includes several research articles presented at leading cancer conferences like the American Society of Clinical Oncology (ASCO) & European Society of Medical Oncology (ESMO) annual conferences.
Oncology Specialist: Personalized Medicines for
Patients
With almost two decades of experience in Molecular Oncology, Dr Chirantan Bose has witnessed patients' struggles with rising healthcare costs. He emphasizes the importance of incorporating molecular genomics strategies into the ‘Standard of Care.’ Personalized medicine in cancer care not only establishes prolonged disease-free survival but also alleviates the adverse effects of ineffective medication, bridging gaps in healthcare expenditures.
Success Stories
Dr. Chirantan Bose shares some of his case studies which
continue to motivate him: He reminisces of a young lawyer from Ghatkopar,
Mumbai, diagnosed with breast cancer during her first trimester of pregnancy,
underwent surgery followed by chemotherapy and delivered a healthy boy, who is
now three years old.
He also recollected about an officer from the postal
department diagnosed with one of the most aggressive cancers, Leiomyosarcoma,
which had metastasized to her lungs. With kids in school, she underwent cancer
treatment for four years. Personalized treatment was administered in 2018, and
she continues to be disease-free till date.
Dr. Chirantan Bose is inspired by the fact how information
contained in our genes is coming to light with ever enhancing technologies and
is contributing to make meaningful difference in lives of patients across the
world, navigating them from hopelessness to happier and productive lives.
Post a Comment